This study found a significant difference between benign and malignant epithelial ovarian tumours with respect to HE4 and ROMA levels, hence, the study suggests a possible role for the use of HE4 and ROMA index as a diagnostic marker for detecting epithelial ovarian cancer. This evidence concerns the gene WFDC2 and ovarian carcinoma.